|1.||Sakač, Marija N: 1 article (12/2013)|
|2.||Gaši, Katarina M Penov: 1 article (12/2013)|
|3.||Djurendić, Evgenija A: 1 article (12/2013)|
|4.||Celić, Andjelka S: 1 article (12/2013)|
|5.||Petri, Edward T: 1 article (12/2013)|
|6.||Jakimov, Dimitar S: 1 article (12/2013)|
|7.||Ajduković, Jovana J: 1 article (12/2013)|
|8.||Klisurić, Olivera R: 1 article (12/2013)|
|9.||Vrbíková, Jana: 1 article (11/2011)|
|10.||Kubátová, Jana: 1 article (11/2011)|
|1.||Aplastic Anemia (Anemia, Hypoplastic)
01/01/1984 - "A study of the efficacy of 5 alpha- and 5 beta-androstanes in chronic experimental aplastic anemia in mice."
01/01/1985 - "Historically oral androstanes have been helpful in the treatment of chronic aplastic anemia. "
01/01/1985 - "In the recovery phase of the aplastic anemia patients treated with immune suppression or androstanes the peripheral blood reflects an altered proliferation of the marrow stem cell. "
01/01/1985 - "The long-range survival in large cooperative groups of patients treated with androstanes have indicated that both severe and chronic aplastic anemia have had responses similar to immune suppressive therapy. "
12/01/1981 - "Effects of androstanes on aplastic anemia--a prospective study."
|2.||Prostatic Neoplasms (Prostate Cancer)
12/01/2013 - "In addition, several 17(E)-picolinylidene androstanes demonstrated selective antiproliferative activity against PC3 prostate cancer cells, which correlates with Abiraterone antiproliferative activity and predicted CYP17A1 binding affinities. "
12/01/2013 - "Virtual screening by molecular docking against clinical targets of steroidal anticancer drugs (ERα, AR, Aromatase and CYP17A1) suggests that 17(E)-picolinylidene, but not 17α-picolyl androstanes could specifically interact with CYP17A1 (17α-hydroxylase) with similar geometry and affinity as Abiraterone, a 17-pyridinyl androstane drug clinically used in the treatment of prostate cancer. "
|5.||Dehydration (Water Stress)
|3.||Anticonvulsants (Antiepileptic Drugs)